All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CENTESSA PHARMACEUTICALS PLC Last Reported: 1/31/2024 Stock Symbol: CNTA

Business Address

3RD FLOOR
1 ASHLEY ROAD
ALTRINCHAM, CHESHIRE , GB WA14 2DT

Mailing Address

3RD FLOOR
1 ASHLEY ROAD
ALTRINCHAM, CHESHIRE , GB WA14 2DT
Phone Number: 44 7391 789784 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 9/30/2020 6/30/2020
Cash and Cash Equivalents $171,498,000.00 $145,220,000.00 $444,800,000.00 $484,161,000.00 $595,100,000.00 $578,800,000.00 $613,759,000.00 -- -- $7,227,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $22,653,000.00 $19,675,000.00 $12,186,000.00 $16,395,000.00 $18,300,000.00 $14,219,000.00 $15,984,000.00 -- -- $1,305,000.00 -- --
Total Current Assets $332,453,000.00 $350,413,000.00 $476,990,000.00 $519,498,000.00 $628,774,000.00 $611,645,000.00 $643,682,000.00 -- -- $11,165,000.00 -- --
Property Plant and Equipement $1,102,000.00 $1,145,000.00 $552,000.00 $905,000.00 $162,000.00 $114,000.00 $74,800.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $2,102,000.00 $2,267,000.00 -- -- $699,000.00 -- -- -- -- -- -- --
Total Assets $377,364,000.00 $392,921,000.00 $479,355,000.00 $521,051,000.00 $629,635,000.00 $612,207,000.00 $643,757,000.00 -- -- $11,717,000.00 -- --
Accounts Payable $10,848,000.00 $11,085,000.00 $10,858,000.00 $8,229,000.00 $8,065,000.00 $18,456,000.00 $7,261,000.00 -- -- $1,032,000.00 -- --
Accrued Liabilities $24,106,000.00 $22,782,000.00 $27,333,000.00 $25,340,000.00 $16,573,000.00 $10,688,000.00 $16,924,000.00 -- -- $1,047,000.00 -- --
Total Current Liabilities $117,974,000.00 $116,315,000.00 $106,434,000.00 $101,012,000.00 $138,081,000.00 $63,074,000.00 $58,115,000.00 -- -- $8,619,000.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $779,000.00 $946,000.00 $-1,695,000.00 $-1,142,000.00 $688,000.00 $2,738,000.00 $3,225,000.00 -- -- -- -- --
Accumulated Deficit $-716,100,000.00 $-677,460,000.00 $-558,687,000.00 $-504,812,000.00 $-385,700,000.00 $-324,879,000.00 $-284,700,000.00 -- -- -- -- --
Total Stockholders' Equity $259,390,000.00 $276,606,000.00 $372,921,000.00 $420,039,000.00 $491,554,000.00 $549,133,000.00 $585,642,000.00 $278,634,000.00 $-4,651,000.00 -- -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $377,364,000.00 $392,921,000.00 $479,355,000.00 $521,051,000.00 $629,635,000.00 $612,207,000.00 $643,757,000.00 -- -- $11,717,000.00 -- --

Statement of Operations

Date 9/30/2023 6/30/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 9/30/2020 6/30/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- --
Research and Development -- -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-136,105,000.00 $-95,896,000.00 $-170,660,000.00 $-121,632,000.00 $-374,084,000.00 $-315,792,000.00 $-277,478,000.00 -- $-721,000.00 -- $-2,116,000.00 $-5,319,000.00
Loss Before Income Taxes $-41,474,000.00 $-98,974,000.00 $-173,117,000.00 $-119,101,000.00 $-380,957,000.00 -- -- -- -- -- -- --
Earnings Per Share Basic $-1.20 $-0.26 $-0.57 $-1.29 $-5.07 $-0.45 $-4.89 -- -- -- -- --
Weighted Average Shares Basic 96,648,110 95,050,940 92,994,990 94,109,089 75,166,456 89,899,454 57,309,693 -- -- -- -- --
Earnings Per Share Diluted $-0.40 $-0.80 $-0.57 $-0.69 $-5.07 $-0.45 $-0.65 -- -- -- -- --
Weighted Average Shares Diluted 96,648,110 95,050,940 94,327,914 94,109,089 75,166,456 69,597,648 63,516,656 -- -- -- -- --
Common Stock Shares Authorized 152,500,000 152,500,000 152,500,000 152,500,000 152,500,000 89,900,425 89,899,419 -- -- -- -- --
Common Stock Shares Outstanding 97,567,483 95,299,673 94,571,651 94,271,917 89,988,228 89,900,425 89,899,419 -- -- -- -- --
Common Stock Value $271,000.00 $266,000.00 $263,000.00 $263,000.00 $252,000.00 $252,000.00 $252,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- 22,840,902 22,840,902 22,840,902 -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- $0.00 $0.00 $0.00 -- -- -- -- --
Share Price $6.47 $6.19 -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com